Neurontin (Gabapentin)

Gabapentin is employed in the management of several neurological and neuropathic pain conditions that stem from abnormal neuronal excitability and altered calcium channel function.

• Partial seizures: Decreases the frequency and severity of focal seizure episodes when added to existing antiepileptic regimens.
• Postherpetic neuralgia: Alleviates persistent burning and stabbing pain that follows shingles, improving patient comfort and functional ability.
• Diabetic peripheral neuropathic pain: Reduces numbness, tingling, and shooting pain in the feet and legs of diabetic patients.
• Restless legs syndrome: Diminishes uncomfortable leg sensations and the urge to move, helping patients achieve better sleep quality.

• Gabapentin binds selectively to the α2δ subunit of voltage‑gated calcium channels in central nervous system neurons. This interaction reduces calcium influx during depolarization, leading to decreased release of excitatory neurotransmitters such as glutamate, substance P, and norepinephrine. The net effect is attenuation of neuronal hyperexcitability that underlies seizure activity and neuropathic pain signaling. By modulating these pathways, gabapentin helps restore normal neuronal firing patterns without directly blocking sodium channels.

Gabapentin may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects

• Dizziness: sensation of light‑headedness or unsteadiness.
• Somnolence: increased sleepiness or fatigue.
• Peripheral edema: swelling of the lower limbs.
• Nausea: upset stomach and possible vomiting.

Serious or Rare Side Effects

• Severe allergic reaction: rash, itching, swelling, or difficulty breathing.
• Suicidal thoughts: emergence of depression or suicidal ideation.
• Acute respiratory depression: marked breathing difficulty, especially when combined with depressants.
• Angioedema: rapid swelling of face, lips, tongue, or throat.

When prescribing gabapentin, clinicians should consider several precautionary measures to ensure safe use.

• Renal impairment: dose adjustment may be required in patients with reduced kidney function.
• CNS depression: avoid concomitant use with other sedatives or alcohol.
• Pregnancy: limited data; use only if potential benefit outweighs risk.
• Elderly: start with low dose and monitor for falls or confusion.
• Suicidality: monitor for mood changes and emergent suicidal thoughts.
• Store at ambient temperature: keep tablets in original container, protect from moisture and heat.

Gabapentin can affect, or be affected by, other medicines; awareness of key interactions helps prevent adverse outcomes.

Major Interactions (Avoid)

• Antacids containing aluminum or magnesium: markedly reduce gabapentin absorption; separate dosing by at least 2 hours.
• Opioids (e.g., morphine, oxycodone): combined CNS depression may increase risk of respiratory depression and sedation.

Moderate Interactions (Monitor Closely)

• CNS depressants (benzodiazepines, antihistamines): may enhance drowsiness; monitor patient response.
• CYP3A4 inducers (carbamazepine, phenytoin): may lower gabapentin levels, reducing efficacy.
• Diuretics (furosemide): can increase risk of peripheral edema; observe for swelling.